The chapters cover efficacy, treatment, causes of treatment failure, clinical care, guidelines, pharmacology. The volume closes with an outlook on future perspectives.

However, most infected individuals live in the poorest regions of the world, where ART is virtually nonexistent. The consequent death toll in these regionsâ€"especially sub-Saharan Africaâ€"is begetting economic and social collapse.

This volume is the outcome of the 'call for abstracts' put out by OSSREA in 2011 for senior researchers, social scientists and practitioners to write scientific articles on issues surrounding ARVs.

This book marks the tenth anniversary of HAART, and reviews both the achievements to date, and an exploration of the challenges that may arise in the future.

In Reverse Transcriptase Inhibitors in HIV/AIDS Therapy, leading experts in AIDS/HIV drug discovery and development review all aspects of RTIs (nucleosides, nucleotides, and non-nucleosides), including drug discovery, pharmacology, ...

This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations.

A joint publication of Sidaction, the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization

Drugs are everywhere--on our streets, in our homes, and in our schools--but the straight facts about drugs are not.

This first part of a 2-part issue of Infectious Disease Clinics, edited by Michael S. Saag, MD and Henry Masur, MD, is devoted to HIV/AIDS.

In the mid-1990s new treatment options introduced a new era of AIDS. This book is a sophisticated study of the shaping of this new era.